Skip to main content
Clinical Trials/ISRCTN15526470
ISRCTN15526470
Completed
Phase 2

An investigation of a smart insole, for the purpose of improving sensory response in people with diabetic peripheral neuropathy - SMARTSOLE

Manchester Metropolitan University0 sites22 target enrollmentAugust 16, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetic peripheral neuropathy due to type 2 diabetes
Sponsor
Manchester Metropolitan University
Enrollment
22
Status
Completed
Last Updated
last year

Overview

Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38536962/ (added 06/06/2024)

Registry
who.int
Start Date
August 16, 2023
End Date
April 30, 2022
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Diagnosis of type 2 diabetes mellitus
  • 2\. Aged \>18 years
  • 3\. Presence of at least one pedal pulse
  • 4\. Presence of moderate diabetic peripheral neuropathy defined by a vibration perception threshold \> 15V
  • 5\. Ability to walk unaided for 30 steps
  • 6\. Able to understand all of the study requirements
  • 7\. Fit shoe size UK 8\-12

Exclusion Criteria

  • 1\. Active foot ulcer
  • 2\. NHS prescription footwear
  • 3\. Lower limb amputation (anything more than amputation of two lesser toes)
  • 4\. Severe deformity due to Charcot Neuroarthropathy
  • 5\. Major foot deformities, including diabetes and non\-diabetes\-related deformities
  • 6\. Dementia or other cognitive impairment
  • 7\. Significant cardiopulmonary or other systemic disease limiting the patient’s ability to walk 30 steps
  • 8\. Person with bodyweight greater than 100kg (due to insole device limitations)
  • 9\. Use of a pacemaker
  • 10\. Inability to understand verbal and written information in English

Outcomes

Primary Outcomes

Not specified

Similar Trials